200 related articles for article (PubMed ID: 38194201)
41. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma).
Matolcsy A; Inghirami G; Knowles DM
Blood; 1994 Mar; 83(5):1363-72. PubMed ID: 8118038
[TBL] [Abstract][Full Text] [Related]
42. Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemia.
Jain P; Hu S; Jabbour E; Takahashi K; Pemmaraju N; O'Brien S; Mulanovich VE; Estrov Z
Am J Hematol; 2015 Aug; 90(8):752-3. PubMed ID: 25850565
[No Abstract] [Full Text] [Related]
43. Hodgkin's lymphoma variant of Richter's syndrome.
Vasilj A; Kojić-Katović S; Maricević I; Zokvić E; Kelcec IB; Tomas D; Curić-Jurić S
Coll Antropol; 2010 Mar; 34(1):295-9. PubMed ID: 20437646
[TBL] [Abstract][Full Text] [Related]
44. Progressive multifocal leukoencephalopathy with concurrent Richter's syndrome.
Saad ED; Thomas DA; O'Brien S; Fuller GN; Medeiros LJ; Forman A; Albitar M; Schomer D; Kantarjian HM; Keating MJ
Leuk Lymphoma; 2000 Jun; 38(1-2):183-90. PubMed ID: 10811461
[TBL] [Abstract][Full Text] [Related]
45. Richter's transformation presenting as an obstructing endobronchial lesion.
Milkowski DA; Worley BD; Morris MJ
Chest; 1999 Sep; 116(3):832-5. PubMed ID: 10492297
[TBL] [Abstract][Full Text] [Related]
46. A phase two study of high dose blinatumomab in Richter's syndrome.
Thompson PA; Jiang X; Banerjee P; Basar R; Garg N; Chen K; Kaplan M; Nandivada V; Cortes AKN; Ferrajoli A; Keating MJ; Peterson CB; Andreeff M; Rezvani K; Wierda WG
Leukemia; 2022 Sep; 36(9):2228-2232. PubMed ID: 35941212
[TBL] [Abstract][Full Text] [Related]
47. Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.
Thyagarajan B; Alagusundaramoorthy SS; Shah L; Agrawal A
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27288204
[TBL] [Abstract][Full Text] [Related]
48. The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor.
Wang Y; Rabe KG; Bold MS; Shi M; Hanson CA; Schwager SM; Call TG; Kenderian SS; Muchtar E; Hayman SR; Koehler AB; Fonder AL; Chanan-Khan AA; Van Dyke DL; Slager SL; Kay NE; Ding W; Leis JF; Parikh SA
Haematologica; 2020 Nov; 105(11):2675-2678. PubMed ID: 33131260
[No Abstract] [Full Text] [Related]
49. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
50. Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome.
Fischer A; Bastian S; Cogliatti S; Mey U; Saub J; Schanz U; Padberg B; Hohloch K
Hematol Oncol; 2018 Feb; 36(1):370-371. PubMed ID: 28681549
[No Abstract] [Full Text] [Related]
51. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome.
Matolcsy A; Casali P; Knowles DM
Ann N Y Acad Sci; 1995 Sep; 764():496-503. PubMed ID: 7486574
[TBL] [Abstract][Full Text] [Related]
52. Ibrutinib has some activity in Richter's syndrome.
Giri S; Hahn A; Yaghmour G; Martin MG
Blood Cancer J; 2015 Jan; 5(1):e277. PubMed ID: 25635530
[No Abstract] [Full Text] [Related]
53. Primary digestive Richter's syndrome.
Parrens M; Sawan B; Dubus P; Lacombe F; Marit G; Vergier B; Reiffers J; de Mascarel A; Merlio JP
Mod Pathol; 2001 May; 14(5):452-7. PubMed ID: 11353056
[TBL] [Abstract][Full Text] [Related]
54. Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib.
Koshiishi M; Odate T; Nakagawa Y; Suzuki J; Kumagai T; Kawashima I; Yamamoto T; Nakajima K; Tanaka M; Oishi N; Kondo T; Kirito K
Intern Med; 2021 Oct; 60(20):3305-3308. PubMed ID: 33896865
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review.
Soilleux EJ; Wotherspoon A; Eyre TA; Clifford R; Cabes M; Schuh AH
Histopathology; 2016 Dec; 69(6):1066-1076. PubMed ID: 27345622
[TBL] [Abstract][Full Text] [Related]
56. Current trends in the management of Richter's syndrome.
Allan JN; Furman RR
Int J Hematol Oncol; 2018 Dec; 7(4):IJH09. PubMed ID: 30651968
[TBL] [Abstract][Full Text] [Related]
57. Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?
Sachanas S; Pangalis GA; Moschogiannis M; Yiakoumis X; Koulieris E; Tsirkinidis P; Kalpadakis C; Rontogianni D
Anticancer Res; 2017 Jun; 37(6):3277-3280. PubMed ID: 28551676
[TBL] [Abstract][Full Text] [Related]
58. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
59. Hypercalcemia in a patient with chronic lymphocytic leukemia evolving into Richter's syndrome.
Briones J; Cervantes F; Montserrat E; Rozman C
Leuk Lymphoma; 1996 May; 21(5-6):521-3. PubMed ID: 9172822
[TBL] [Abstract][Full Text] [Related]
60. A cultured malignant B-1 line serves as a model for Richter's syndrome.
Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES
J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
